Sphingolipidosis

Sphingolipidosis (pronunciation: sfing-go-li-po-di-dosis) is a group of inherited metabolic disorders, characterized by the abnormal accumulation of sphingolipids in cells and tissues.

Etymology

The term "Sphingolipidosis" is derived from the word "sphingosine", a type of lipid that is a component of sphingolipids, and "-osis", a suffix in medical terminology that indicates an abnormal condition or disease.

Types of Sphingolipidosis

There are several types of sphingolipidoses, including:

Each of these diseases is caused by a deficiency in a specific enzyme that is necessary for the metabolism of sphingolipids.

Symptoms

The symptoms of sphingolipidoses vary depending on the specific type of disease, but they can include neurological problems, organ enlargement, bone pain, and skin changes.

Diagnosis

Diagnosis of sphingolipidoses typically involves genetic testing to identify mutations in the genes that encode the enzymes involved in sphingolipid metabolism.

Treatment

Treatment for sphingolipidoses is primarily supportive and symptomatic, as there is currently no cure for these diseases. Enzyme replacement therapy and substrate reduction therapy are two treatment options that can help manage symptoms.

External links

Medical encyclopedia article on Sphingolipidosis
Wikipedia's article - Sphingolipidosis

This WikiMD dictionary article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Sphingolipidosis